| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 295 | 10.413 | 15.967 | 20.248 | 36.115 |
| Total Income - EUR | - | - | - | - | - | 295 | 10.413 | 15.967 | 20.248 | 37.703 |
| Total Expenses - EUR | - | - | - | - | - | 4.151 | 7.771 | 12.029 | 12.848 | 21.692 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -3.855 | 2.643 | 3.937 | 7.400 | 16.011 |
| Net Profit/Loss - EUR | - | - | - | - | - | -3.864 | 2.330 | 3.482 | 6.152 | 13.476 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Reumatomed Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 23 | 371 | 2.998 | 3.608 | 18.555 |
| Current Assets | - | - | - | - | - | 53 | 265 | 1.340 | 5.419 | 7.652 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 543 |
| Receivables | - | - | - | - | - | 43 | 20 | 0 | 436 | 0 |
| Cash | - | - | - | - | - | 10 | 246 | 1.340 | 4.983 | 7.110 |
| Shareholders Funds | - | - | - | - | - | -3.823 | -1.408 | 2.070 | 8.216 | 21.646 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.940 | 2.045 | 2.267 | 811 | 4.675 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Reumatomed Health S.r.l.